Evidence for a superantigen in the pathogenesis of tuberculosis
- 1 December 1996
- journal article
- review article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 17 (4) , 375-384
- https://doi.org/10.1007/bf01795135
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistanceEuropean Journal of Immunology, 1995
- Interleukin 12 at the site of disease in tuberculosis.Journal of Clinical Investigation, 1994
- HLA class II molecule‐mediated signal transduction mechanism responsible for the expression of interleukin‐1β and tumor necrosis factor‐α genes induced by a staphylococcal superantigenEuropean Journal of Immunology, 1993
- Characterization of T cell repertoire changes in acute Kawasaki disease.The Journal of Experimental Medicine, 1993
- Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity.The Journal of Experimental Medicine, 1993
- Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.The Journal of Experimental Medicine, 1992
- Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22.The Journal of Experimental Medicine, 1992
- Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.The Journal of Experimental Medicine, 1992
- Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.The Journal of Experimental Medicine, 1992
- Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.The Journal of Experimental Medicine, 1990